Adipo Therapeutics completes $1.9 million seed funding bridge to advance obesity and Type 2 diabetes treatment
INDIANAPOLIS — Adipo Therapeutics, a late-stage, preclinical biopharmaceutical company developing treatments for obesity and Type 2 diabetes, announced on Wednesday (Jan. ...